Clinical trial
Enhancing Influenza Vaccination in Seniors With TLR (Toll Like Receptor) Agonists
NCT01737580 is registered in ClinicalTrials.gov with University of British Columbia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Enhancing Influenza Vaccination in Seniors With TLR (Toll Like Receptor) Agonists
- Lead sponsor
- University of British Columbia
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- April 30, 2013
- Completion date
- June 30, 2013
- Enrollment
- 59 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
influenza vaccination in seniors